- Joined
- Apr 7, 2008
- Messages
- 178
- Reaction score
- 0
There are 2 groups of lysosomal storage diseases. In Group I, there are 2 diseases, Smith syndrome and Jones syndrome, each of which is lacking a different lysosomal hydrolase, resulting in accumulation of a glycosaminoglycan within lysosomes. There is an isolated cells from patients with Smith syndrome and patients with Jones syndrome. When cells from the 2 syndromes are fused, glycosaminoglycans are now degraded properly.
In addition, surprisingly, when the medium (supernatant = solution outside of the cells) from a culture of Smith cells (donor) is added to a culture of Jones cells (recipient), the Jones defect is corrected (Jones glycosaminoglycan is now degraded).
In Group II, there are 3 diseases, all due to a defect in the sorting of hydrolases from the Golgi to the lysosome: 2 are due to defects in the enzymatic processing of the mannose 6-phosphate marker on the
hydrolase (GlcNAc phosphotransferase and GlcNAc phosphoglycosidase, diagrammed below) and one is due to a mutation in the M6P receptor that targets the hydrolase to the lysosomal surface. Group II diseases result in functional hydrolases that are secreted from the cell rather than being transported to lysosomes.
Isolated cells (A, B, and C) from patients with each of the 3 specific Group II diseases.
Experiments with supernatants from these cell lines give the results below:
Result 1. The supernatant from normal cells corrects the defects in A and B but not the defect in C.
Result 2. The supernatant from C corrects the defect in cells from patients with Jones syndrome but the supernatants from A and B do not.
Result 3. If the supernatants from the mutant cells are first treated with an enzyme to remove GlcNAc, then the supernatants from C and B correct the defect in Jones cells, but the supernatant from A does not.
The figure is attached.
Defect in GlcNAc phosphotransferase come from which cell line?
A- A
B- B
C- C
D- none
Defect in GlcNAc phosphoglycosidase come from which cell line?
A- A
B- B
C- C
D- none
Defect in M6P receptor come from which cell line?
A- A
B- B
C- C
D- none
In addition, surprisingly, when the medium (supernatant = solution outside of the cells) from a culture of Smith cells (donor) is added to a culture of Jones cells (recipient), the Jones defect is corrected (Jones glycosaminoglycan is now degraded).
In Group II, there are 3 diseases, all due to a defect in the sorting of hydrolases from the Golgi to the lysosome: 2 are due to defects in the enzymatic processing of the mannose 6-phosphate marker on the
hydrolase (GlcNAc phosphotransferase and GlcNAc phosphoglycosidase, diagrammed below) and one is due to a mutation in the M6P receptor that targets the hydrolase to the lysosomal surface. Group II diseases result in functional hydrolases that are secreted from the cell rather than being transported to lysosomes.
Isolated cells (A, B, and C) from patients with each of the 3 specific Group II diseases.
Experiments with supernatants from these cell lines give the results below:
Result 1. The supernatant from normal cells corrects the defects in A and B but not the defect in C.
Result 2. The supernatant from C corrects the defect in cells from patients with Jones syndrome but the supernatants from A and B do not.
Result 3. If the supernatants from the mutant cells are first treated with an enzyme to remove GlcNAc, then the supernatants from C and B correct the defect in Jones cells, but the supernatant from A does not.
The figure is attached.
Defect in GlcNAc phosphotransferase come from which cell line?
A- A
B- B
C- C
D- none
Defect in GlcNAc phosphoglycosidase come from which cell line?
A- A
B- B
C- C
D- none
Defect in M6P receptor come from which cell line?
A- A
B- B
C- C
D- none